CXCL17 is dispensable during hypervirulent Mycobacterium tuberculosis HN878 infection in mice

Authors

José Alberto Choreño-Parra, Washington University School of Medicine in St. Louis
Micah D Dunlap, Washington University School of Medicine in St. Louis
Rosemary Swanson, Washington University School of Medicine in St. Louis
Luis A Jiménez-Álvarez, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
Marcela Muñoz-Torrico, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
Silvia Guzmán-Beltrán, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
Joaquín Zúñiga, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
Shabaana A Khader, Washington University School of Medicine in St. Louis

Journal

Immunohorizons

Publication Date

9-24-2021

Volume

5

Issue

9

First Page

752

Last Page

759

Document Type

Open Access Publication

DOI

10.4049/immunohorizons.2100048

Rights and Permissions

Choreño-Parra JA, Dunlap MD, Swanson R, Jiménez-Álvarez LA, Muñoz-Torrico M, Guzmán-Beltrán S, Zúñiga J, Khader SA. CXCL17 Is Dispensable during Hypervirulent Mycobacterium tuberculosis HN878 Infection in Mice. Immunohorizons. 2021 Sep 24;5(9):752-759. doi: 10.4049/immunohorizons.2100048 Copyright © 2021 The Authors This article is distributed under the terms of the CC BY 4.0 Unported license.

Recommended Citation

Choreño-Parra, José Alberto; Dunlap, Micah D; Swanson, Rosemary; Jiménez-Álvarez, Luis A; Muñoz-Torrico, Marcela; Guzmán-Beltrán, Silvia; Zúñiga, Joaquín; and Khader, Shabaana A, "CXCL17 is dispensable during hypervirulent Mycobacterium tuberculosis HN878 infection in mice." Immunohorizons. 5, 9. 752 - 759. (2021).
https://digitalcommons.wustl.edu/oa_4/3873

Department

ICTS (Institute of Clinical and Translational Sciences)